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ABSTRACT 
As part of the project to identify plant natural products which modulate bacterial multidrug resis-
tance (MDR), bioassay-guided isolation of the methanol extract of Paullinia pinnata L. roots yielded 
four known compounds namely friedelin, β-sitosterol, β-sitosterol acetate and β-sitosterol D-
glucoside. The structures were established by spectros opic methods and comparison with published 
data. These compounds were tested for in vitro antibacterial and resistance modifying activities 
against strains of Staphylococcus aureus; SA1199B, RN4220 and XU212 possessing the Tet(K), Msr
(A), and Nor(A) multidrug resistance efflux mechanisms respectively. At 10µg/ml, none of the com-
pounds displayed any antibacterial action but in combination with tetracycline, erythromycin and 
norfloxacin, friedelin displayed a 2-fold, 4-fold and 16-fold potentiation of activities of these antibiot-
ics against XU212, SA1199B and RN4220 possessing the Tet(K) [tetracycline resistant], Nor(A) 
[norfloxacin resistant] and Msr(A) [macrolide resistant] transporters respectively. 
Keywords: Paullinia pinnata, resistance modulators, friedelin, Staphyloccocus aureus. 
INTRODUCTION 
The effectiveness of the arsenal of antibiotics 
now in use, including methicillin, is decreasing in 
the face of emerging bacterial resistance and has 
been the subject of various reviews and research. 
During the last two decades, new infectious dis-
eases have appeared e.g Ebola and Buruli ulcer, 
and some old ones previously thought to be con-
trolled e.g gonorrhoea, have re-emerged (Casell 
and Mekalonos, 2001). Furthermore, the useful-
ness of existing antimicrobial agents is rapidly 
fading, tipping the balance in favour of multi-
drug resistant pathogens, including MRSA, and 
there appears to be few, if any, new classes of 
drugs currently in use to fight against the multi-
drug resistant pathogens. Multidrug-resistance 
(MDR) exhibited by many bacterial species is a 
major problem in treating both hospital and com-
munity acquired infections. Many strains of 
MRSA possess efflux pumps such as the specific 
TetK and MsrA transporters which export or ex-
trude certain tetracyclines and macrolides, and the 
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multidrug resistance proteins NorA and QacA 
which confer resistance to a wide range of struc-
turally unrelated antibiotics (Koyama, 2006). The 
inhibition of efflux pumps or mechanism in a 
bacterial cell could therefore be a means of re-
versing resistance. 
A bacterial resistance modifying agent therefore, 
reduces the minimum inhibitory concentration 
(MIC) for an antibiotic to which resistance has 
already occurred. This could be of great benefit in 
combinatory therapy, perhaps facilitating the re-
introduction of antibiotics that are no longer ef-
fective due to resistance (Gibbons, 2005). An 
example of synergistic combination in commer-
cial antibacterial chemotherapy in the treatment 
of various infections is AugmentinTM, comprising 
β-lactamase inhibitor, clavulanic acid with amox-
icillin. As part of an ongoing study, the antibacte-
rial activity of Paullinia pinnata L. against three 
resistant strains of Staphylococcus aureus; 
SA1199B, RN4220, XU212 had been assessed by 
Annan et al. (2005).  We here report the effect of 
the isolates from the methanolic extract on the 
resistant Staphylococcus trains and also in com-
bination with standard antibiotics tetracycline, 
erythromycin and norfloxacin respectively. These 
were tested against the bacteria strains to which 
they are resistant. 
 
MATERIALS AND METHODS  
Plant materials 
Plant materials were collected in June 2005 and 
authenticated at the Centre for Scientific Research 
into Plant Medicine (CSRPM), Akwapim-
Mampong, Ghana, where voucher specimen 
13/05/013 has been deposited. 
 
Preparation of extracts 
50 gm of the dried powdered roots was packed 
into a cellulose thimble (28x100 mm) and soxhlet
-extracted with 400ml methanol (Sigma) over 48 
hours until the material was exhausted. The ex-
tract was concentrated under reduced pressure 
using the rotary evaporator and dried over nitro-
gen to give a yield of 3.21gm. 
Isolation of compounds 
Column chromatography was used to isolate com-
pounds from the active chloroform fraction. 
2.0gm of material was packed over 150g silica 
gel [(0.040-0.060mm) 230-400 mesh ASTM] 
using the wet method. Gradient elution was em-
ployed, starting with 1% ethyl acetate in petro-
leum ether (40-60oC) and ending with 100% ethyl 
acetate. 30 x 200ml aliquots were collected (1-30) 
and concentrated under reduced pressure. Based 
upon the TLC (thin layer chromatography) analy-
sis of the thirty different aliquots, 1-4 were 
bulked and further purified to yield 1 (24.3mg). 
Aliquots 5-9 were bulked and further crystallized 
in chloroform to yield 2 (33.4mg). Aliquots 10-13 
were bulked, subjected to further column chroma-
tography to yield 3 (425mg). Aliquots 16-30 were 
bulked, subjected to further column chromatogra-




The NMR (both 1H and 13C) spectra were deter-
mined with the assistance of the Chemistry De-
partment, King’s College, London. 1H and 13C-
NMR were recorded on a Bruker DPX 600 spec-
trometer (ppm, J in Hz) using TMS as internal 
standard. DEPT and 2D-NMR experiments were 
also carried out on the same instrument. 
 
Bacteria used 
The resistant bacteria used for the tests were a 
kind donation from Prof. Simon Gibbons of Cen-
tre for Pharmacognosy and Phytotherapy, The 
School of Pharmacy, University of London and 
included resistant strains of Staphylococcus 
aureus SA1199B, RN4220, XU212.   
 
Antibacterial assay 
Inocula of the bacteria were prepared from the 24 
h Mueller-Hinton broth (Sigma) cultures and sus-
pensions were adjusted to 105CFU/ml. Isolates 
were dissolved in 2% dimethylsulphoxide 
(DMSO). MIC values of the isolates were deter-
mined based on a micro-well dilution method 
(Eloff, 1998). The 96-well sterile plates were pre-
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pared by dispensing 180 µl of the inoculated 
broth plus a 20 µl aliquot of the isolate made up 
in broth or 20 µl broth in the case of negative 
control in each well. Tetracycline (Sigma) was 
included as positive control. Plates were incu-
bated for 24 h at 37oC. Bacterial growth was de-
termined after addition of 50µl p-iodonitro-
tetrazolium blue (0.2 mg/ml, Sigma). 
 
Bacterial resistance modulation assay 
The modulation assay was performed using 10µg/
ml of the isolated compounds to find the effect of 
combining them with standard antibiotics nor-
floxacin, tetracycline and erythromycin on resis-
tant strains of Staph. aureus SA1199B (NorA), 
XU212 (tetK) and RN4220 (MsrA) respectively 
following the method of Oluwatuyi et al. (2004). 
100µl of Muller Hinton Broth (MHB) was placed 
in each well except wells in column 1. 200µl of 
antibiotic was placed in wells of column 1 and 
serially diluted 2-fold to give a dilution range 512
-1µg/ml. To the wells in first three rows were 
added 100µl of the compound (made so as to 
bring the net concentration in each well to 10µg/
ml) except those in columns 11 and 12. To the 
wells in rows four to six were added 100µl of 
reserpine (solution made so as to bring the net 
concentration in well to 10µg/ml). Wells in rows 
seven and eight were however, maintained free 
from both the isolate and reserpine. Wells in col-
umns 11 and 12 were used as general and sterile 
controls respectively. Plates were incubated at 
37oC for 24 hours, after which 20µl of MTT was 
added to each well and incubated for further 30 
minutes. Inhibition of bacterial growth was visi-
ble as a clear well and the presence of growth 
detected by the presence of a blue colour in the 
well. All experiments were performed in triplicate 
under aseptic conditions. 
 
RESULTS AND DISCUSSION 
Compound [1] was crystallized out of chloroform 
as fine needle-like crystals with melting point, 
258-259oC (uncorrected). It showed positive Lie-
bermann’s test and IR absorption peaks at (KBr) 
νmax:  2946, 2887, 2868, 1720, 1464, 1384, 1360 
cm-1. MS molecular peak at m/z 426 and other 
fragments at 384, 302, 273, 203, 123, 95, 55; 
characteristic of 3-keto-triterpenoid compounds 
(Budzikiewicz et al., 1964). The 13C-NMR spec-
trum displayed a total of 30 carbon resonances, 
including a carbonyl carbon at δ 213.1. The 
DEPT experiment indicated that 23 out of the 30 
carbon atoms in [1] were attached to protons, 
exhibiting signals for 8 methyls, 11 methylenes, 4 
methines and 7 quarternary carbons. The 1H-
NMR spectrum showed 7 three proton singlets at 
δ 0.71, 0.87, 0.98, 1.00, 1.00, 1.03, 1.18 and a 
doublet centred at δ 0.87. These were attributed to 
H-24, H-25, H-29, H-26, H-30, H-27, H-28 and H
-23. On the basis of the above spectral features, 
[1] was characterized as friedelin [friedelan-3-
one], the identity of which was further substanti-
ated by comparison of its spectroscopic data with 
published values (Rahman et al., 2005). Friedelin 
[1] has been reported in several species from dif-
ferent genera. However, this is being reported for 
the first time in the genus Paullinia. 
On crystallization in chloroform, compound [2] 
was obtained as white needle crystals with melt-
ing point 138-139oC (uncorrected). IR (KBr) 
νmax: 3440, 2900-2850, 1430, 1370, 1615, 1051, 
960 cm-1. LR-EI-MS, m/z (rel. int., %) 414 (90), 
396 (40), 351 (11), 303 (22), 255(33), 213 (22), 
159 (20), 1449 (22), 107 (22), 55 (18). The EI-
MS of [2] exhibited a maximum peak at m/z 414, 
corresponding to the molecular formula C29H50O. 
This is also in close agreement with the literature 
values of β-sitosterol (El Deeb et al., 2003). The 
13C-NMR of [2] also compared with the literature 
(Kovganko et al., 1999).  The unequivocal identi-
fication of [2] was confirmed by direct TLC com-
parison with the reference commercial β-
sitosterol (Sigma-Aldrich, USA, batch number 
47C-0262). Co-chromatography of [2] and the 
reference sample gave identical Rf values and 
chromogenic reaction to spray reagents. β-
sitosterol has been isolated from numerous spe-
cies and different families, including the leaves of 
P. pinnata (Miemanang et al., 2006). 
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On crystallization in methanol, [3] was obtained 
as white amorphous powder with melting point 
118-120oC (uncorrected).  The EI-MS of [3] ex-
hibited a maximum peak at m/z 456, correspond-
ing to the molecular formula C31H52O2. The 
13C-
NMR of [3] also compared with the literature data 
for β-sitosterol acetate (Kovganko et al., 1999). 
The chemical shifts of carbon atoms in rings B, C 
and D and the side chains of [3] and β-sitosterol 
[2], were identical. The differences in the chemi-
cal shifts of the atoms in ring A were as a result 
of the conversion of OH, attached to C-3 in β-
sitosterol, to the acetate. Thus the signal for C-3
in the spectrum of the acetate shifted to downfield 
by ~2 ppm owing to the α-effect of the acetoxy 
group, compared with its position in the spectrum 
of OH in β-sitosterol [2]. The signal for C-2 and 
C-4 in the spectrum of the acetate shift to upfield 
due to the β-effect of the acetoxy group. 
Compound [4] was obtained as an off-white 
amorphous powder. The EI-MS exhibited a maxi-
mum peak at m/z 576, corresponding to the mo-
lecular formula C35H60O6. The 
13C-NMR of [4] 
also compared with the literature data for β-
sitosterol-D-glucoside (Pei-Wu et al., 1988). The 
chemical shifts of carbon atoms in B, C and D 
and the side chains of [4] and β-sitosterol [2], 
were almost identical. The differences in the 
chemical shifts of the atoms in ring A were as a 
result of the change from OH, attached to C-3 in 
β-sitosterol, to the O-glucoside. Glucosidation at 
position C-3 was concluded from the downfield 
chemical shift of carbon C-3 by ~5-12 ppm, com-
pared with its position in the spectrum of β-
sitosterol [2] (Agrawal, 1992). The signal for C-2 
and C-4 in the spectrum of the glucoside shift to 
upfield, can also be ascribed to the β- ffect of the 
glucoryl group. The location of the glucose at C-3 
was further confirmed from the correlation of its 
H-11 at δ 4.12 with C-3 at δ 78.1 in HMBC 
(Heteronuclear Multiple-bond Correlation) and 
COSY (Correlation spectroscopy) experiments. 
Acid hydrolysis of [4] proved β-sitosterol to be 
the aglycone moiety (co-chromatography with 
reference sample) and glucose was the sugar moi-
ety (using butanol-acetic acid-water [5:1:4] in 
paper chromatography, using Whatman no. 4 
paper (catalog no. 4001 150) and aniline hydro-
gen phthalate spray [aniline (0.93g) + phthalic 
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Antimicrobial activity 
Friedelin [1] showed moderate antibacterial activ-
ity against the three resistant strains of Staph 
aureus with MICs ranging between 128 and 256 
µg/ml (Table 1).  The standard antibiotic, used as 
positive controls recorded low MIC values in all 
experiments except against bacterial strains to 
which they are resistant. Friedelin has previously 
been reported by Vasanth et al. (2001) to possess 
antimicrobial properties against Gram positive 
and Gram negative bacteria. β-sitosterol, β-
sitosterol acetate and β-sitosterol-D-glucoside did 
not show antimicrobial actions within the concen-
tration range tested. 
The results of the bacterial resistance modulation 
assay using a sub-lethal concentration, i.e, 10µg/
Minimum inhibitory concentration [MIC] (µg/ml)  
Bacteria 1 2       3          4 TET  ERY NOR 
SA 1199B (NOR A) 256   >512   >512      512 8 8 32 
XU 212 (TetK) 128   >512    >512    >512 128 4 4 
RN 4220 (MsrA) 256  >512    >512    >512 8 256 4 
  
Antimicrobial agent 
MIC (µg/ml) of test strain expressing the indicated efflux protein 
  
XU212 (TetK) RN4220 (MsrA) SA1199B (NorA) 
Tetracycline 128 NT NT 
+  friedelin 64     
+β-sitosterol 128     
+β-sitosterol acetate 128     
+β-sitosterol glucoside 128     
 + reserpine 32     
Erythromycin NT 256 NT 
+  friedelin   16   
+β-sitosterol   256   
+β-sitosterol acetate   256   
+β-sitosterol glucoside   256   
 + reserpine   256   
Norfloxacin NT NT 32 
+  friedelin     16 
+β-sitosterol     32 
+β-sitosterol acetate     32 
+β-sitosterol glucoside     32 
 + reserpine     8 
Table 1: Antibacterial activities of isolated compounds expressed as minimum inhibitory  
  concentrations (MIC) [µg/ml] 
Key; 1 –friedelin ; 2 –β-sitosterol; 3 –β-sitosterol acetate; 4 -β-sitosterol D-glucoside; TET - Tetracycline;  
NOR – Norfloxacin; ERY - Erythromycin; n=3 
Table 2: Antimicrobial susceptibility of test strains in the absence and presence of  10µg/ml of  
  compounds and reserpine 
All MICs were determined in triplicate.   NT = not tested 
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ml, of isolated compounds in addition to different 
concentrations of standard antibiotics showed that 
friedelin [1] was able to reduce the MIC of nor-
floxacin from 32µg/ml to 16µg/ml (2-fold poten-
tiation) against SA1199B. Friedelin also showed 
good modulation actions with erythromycin and 
tetracycline against RN4220 and XU212 respec-
tively. Reserpine, which was used as control 
(Oluwatuyi et al., 2004) had 4-fold potentiation 
of tetracycline activity against XU212 and nor-
floxacin activity against SA1199B (Table 2). 
However, reserpine had no effect on erythromy-
cin against RN4220 (MIC 256 µg/ml) whilst 
friedelin [1] showed a significant effect (16-fold 
potentiation). 
Triplicate experiments were carried out but each 
experiment gave the same MIC for a particular 
extract tested. 
Different classes of compounds of plant origin 
have been found to possess bacterial resistance 
modulatory actions (Gibbons, 2005). These in-
clude alkaloids (Brenwald et al., 1997), flavon-
oids and coumarins (Tsutomu et al., 2005), tan-
nins and saponosides (Lee t al., 2000), diterpe-
noids, triterpenoids and steroids (Silvia et al., 
1999). 
Microbiological resistance mutations may be ex-
pressed in several ways. These include production 
of inactivating enzymes, changes in cell wall per-
meability, alterations to structural target, bypass 
of metabolic pathway, changes in efflux mecha-
nisms and multiple resistance mechanisms 
(Wickens and Wade, 2005). Efflux pumps occur 
naturally in bacterial cells and are concerned with 
the removal of waste products (Poole, 2005). 
However, changes in their conformation can 
make them remove antimicrobials. Gram Positive 
organisms, including Staph. aureus can show 
resistance to tetracyclines by this mechanism 
(Miyamae et al., 2001). However, it is common 
for organisms to exhibit resistance by using a 
combination of two or more of the above mecha-
nisms. Macrolide resistance in Streptococci may 
be due to a combination of increased efflux and 
ribosomal modification, a scenario commonly 
referred to as multi-drug resistance (Di Perri and 
Bonora, 2004). 
In this study, the observed potentiation of the 
antimicrobial effects of the standard antibiotics 
used (tetracycline, erythromycin and norfloxacin) 
after combining them individually with 10 µg/ml 
of friedelin suggests it could modify the resis-
tance mechanisms present. In the case of 
SA1199B, RN4220 and XU212 where the mecha-
nisms of resistance have been confirmed to be by 
efflux (Gibbons, 2005), friedelin in low concen-
trations may act as substrates for the efflux pro-
teins which the resistant bacteria overexpress thus 
allowing the respective antibiotics to enter the 
bacterial cell to cause toxicity. 
 
CONCLUSIONS 
Friedelin, isolated from P. pinnata, has been 
found to be a bacterial resistance modulator. This 
interesting finding is of significance especially in 
a developing country like Ghana, where antibiot-
ics are often abused and taken concurrently with 
herbal medications. This may mean that the con-
current use of herbal extracts (which may contain 
modulatory principles) and clinical antibiotics, 
even at normal therapeutic levels, should be done 
with caution since minute quantities of some 
herbal extracts may act synergistically with the 
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